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SYSTEM FOR THE DIAGNOSIS AND 
MONITORING OF CORONARY ARTERY 
DISEASE, ACUTE CORONARY 
SYNDROMES, CARDIOMYOPATHY AND 
OTHER CARDIAC CONDITIONS 
As shown in FIG. 1, the graphic representation of signals 
that constitute the conventional tracing is limited to visible 
frequencies of about 100 Hz and lower. On the other hand, 
higher component frequencies are known to exist within the 
5 ECG signal, but are not visible to interpreting clinicians 
possessing only conventional ECG equipment. To accu- 
The invention described herein was made in the perfor- rately detect the H F ~  (especially those in the important 
mance of work under a NASA contract and is subject to the 150-250 Hz range), digital sampling rates that exceed those 
provisions of Section 305 of the National Aeronautics and of most conventional ECG manufacturers are first required, 
Space Act of 1958, Public Law 85-568 (72 Stat. 435; 42 10 Traditionally, a clinician looks for changes in the ST seg- 
U.S.C. 2457). ments of conventional LF ECG tracings as a potential 
evidence for myocardial ischemia. However, during actual 
ischemia, diminution of the HF components within the QRS 
particularly to a non-inva- 15 in the conventional ST segments. Thus, the visualization of 
FIELD OF THE INVENTION 
The present invention relates generally to the field of 
sive, real-time processing system and method to analyze, 
process, store, recall and display electrocardiographic sig- 
complex has been shown to occur well Prior to any changes 
HF changes within the entire QRS complex represents 
potentially a much more sensitive way to non-invasively 
e~ectrocardiography, and 
nal s . detect myocardial ischemia in contrast to current conven- 
tional ECG techniques. 
From off-line studies, it is known that a diminution of the 2o BACKGROUND OF THE INVENTION 
amplitude of the HF components within the central portion 
of the QRS complex of the ECG can be a highly sensitive 
alone. Although substantial advancement in the care of 25 example, than changes in the ST segment of the conven- 
patients with ischemic heart disease has recently contributed tional ECG, However, until now, there has been no device 
tive interventions with a similar impact on survival could, in components in the monitored patient, While academic soft- 
theory, avert more than five times as many cardiovascular ware programs have been designed that analyze the central 
deaths each year. Clinicians providing preventive care for 30 HF QRS components, all such programs involve laborious 
disease in the community to the extent that they can identify 
patients at high risk for future vascular events. 
nary artery disease (CAD), acute coronary syndromes 
Cardiovascular disease remains the leading cause of death 
in North America, with more than indicator for the presence of myocardial ischemia, myocar- 
infarctions Occurring in the United States dial infarction, or cardiomyopathy, sensitive, for 
.6 myocardia1 
to a 20-25% in rate, primary Preven- capable ofdisplaying, in real time, changes in these HF QRS 
therefore have an off-line calculations and post-processing, and therefore have 
little if any clinical utility, being strictly research tools, 
in 
to reduce the adverse impact Of 
Thus, there remains a need for a system and method that 
time for usefulness in the clinical environment. Such a 
One key problem, however, is that individuals with core- 35 analyzes HF components Over the entire QRS 
(ACS) and/or other cardiac conditions such as cardiomy- system perform, in time, Of the 
op&y are often difficult to identify, Moreover, up to one digita1 samplin!& and that is required to 
third of life-threatening cardiovascular events occur in the 
absence of traditional CAD risk factors. These consider- 40 thereafter up*te these HF QRS as as 
sive diagnostic techniques that can better Screen for and basis, the diagnostic information being 
obtained from the conventional (Le. low frequency) ECG predict cardiovascular events. 
Diagnosis of abnormal cardiac conditions has relied in the complexes at the Same time. 
past on visible alterations in the P, QRS, and T-waves, i.e. 45 The HF signals in the central Portion of the QRS ECG 
portions ofthe electrocardiograph periodic signal, The elec- complex that have generated the most research interest in 
trocardiograph includes a low frequency (LF) portion terms of off-line detection of ischemia and infarction are 
and an impressed or imbedded high frequency (HF) portion, those signals in the range of 150 to 250 Hz. The raw, analog 
and it has been found that although the HF portion of the ECG Signal is typically sampled at 2500 samples Per 
signal is not particularly visible, it contains information that 50 second (to digitize the Signal) in Order to adequately satisfy 
malities, notably myocardial ischemia and infarction and frequency of interest and in order to retain the information 
cardiomyopathy of any etiology. in the signal without loss. In the past, the sampled data have 
The conventional surface electrocardiogram (ECG) has been stored, and then later Processed to Provide Potentially 
long been used as a diagnostic tool for detecting problems 55 useful information to the rem~rcher. 
with the heart. A representative limb-lead tracing from a On the other hand, Simpson, in U.S. Pat. No. 4,422,459, 
conventional surface ECG in a healthy subject is shown in teaches a system which analyzes only the late portion of the 
FIG. 1. Although the conventional ECG is useful, a signifi- QRS interval and early portion of the ST segment, and in an 
cant percentage of individuals presenting to a hospital off-line fashion (i.e. from previously stored data) to indicate 
emergency room with an actual heart attack will nonetheless 60 cardiac abnormalities, in particular the propensity for car- 
have a normal 12-lead conventional ECG. In addition, the diac arrhythmia. The late portion of a post-MI patient’s QRS 
conventional ECG accurately reflects only the predominant waveform can contain a broader range (40-250 Hz) HF 
LF electrical activity of the heart, as illustrated in FIG. 1. It signal tail potentially indicative of a tendency toward ven- 
tells the clinician little or nothing about the less predominant tricular tachycardia. The system in Simpson digitally pro- 
(lower amplitude) HF components of the heart’s electrical 65 cesses and filters a patient’s QRS signals in a reverse time 
signal embedded within the various lower-frequency waves manner to isolate the HF tail and avoid the filter ringing 
of the conventional ECG. which would otherwise hide the signal. Thus, in order to do 
generate HF QRS signa1s. The system 
ations have led researchers to seek out improved noninva- Other derived parameters, in time On a beat-to-beat 
provides greater sensitivity in determining certain abnor- the Nyquist rate of sampling at at least twice the highest 
US 7,386,340 B2 
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so, Simpson presupposes that the data are stored so that they 
can be processed in reverse time order. 
Albert et al., U.S. Pat. No. 5,117,833, partially focuses on 
analyzing signals within the mid-portion of the QRS interval 
for the indication of cardiac abnormality. The system of 
Albert et al. uses a known technique of building up data 
points to derive an average of heartbeat characteristics in 
order to enhance signal to noise ratio. Data are collected and 
filtered and then stored for subsequent analysis. Thus, the 
system does not teach a cardiac monitor which provides the 
data analysis immediately from the data derived from a 
patient, i.e. in “real-time”. 
Albert et al., U.S. Pat. No. 5,046,504, similarly teaches 
the acquisition of QRS data and subsequent analysis. Rou- 
tine calculations are performed from the data previously 
calculated and stored. Further, this system teaches producing 
a set of digital spectrum values representative of an approxi- 
mate power density spectrum at each of a large number of 
generally equally spaced sampling time intervals of the ECG 
waveform. 
Seegobin, in U.S. Pat. Nos. 5,655,540 and 5,954,664, 
provides a method for identifying CAD. The method relies 
on a database of various frequency ECG data taken from 
known healthy and diseased subjects. Comparison of the 
data has led to a “Score” component, indicating deviation of 
a patient’s data from the norm. This reference is rather 
calculation intensive, relies strictly on signal amplitudes 
rather than signal morphologies, and does not suggest moni- 
toring the condition of a patient, but rather is utilized as an 
off-line diagnostic tool. 
Hutson, U.S. Pat. No. 5,348,020, teaches a technique of 
near real-time analysis and display. The technique includes 
inputting ECG data from multiple, sequential time intervals 
and formatting those data into a two-dimensional matrix. 
The matrix is then decomposed to obtain corresponding 
singular values and vectors for data compression. The com- 
pressed form of the matrix is analyzed and filtered to identify 
and enhance ECG signal components of interest. As with 
other systems, this reference focuses on late potentials, a 
fraction of the QRS interval, as the tool to identify cardiac 
disease. 
Finally, High-Frequency Electrocardiogram Analysis of 
the Entire QRS in the Diagnosis and Assessment of Coro- 
n a y  Artery Disease by Abboud (Progress in Cardiovascular 
Diseases, Vol. XXXV, No. 5 (MarcWApril), 1993: pp 311- 
328) teaches the concept of “reduced amplitude zone” 
(RAZ) as a diagnostic tool. However, this reference also 
uses post-processing, and provides no teaching of a real- 
time analysis system. In the disclosure to follow, the reduced 
amplitude zone as defined in this work may be referred to as 
RAZ,. Further, Abboud et al. used only three ofthe standard 
12 ECG lead positions (specifically leads V3, V4 and V5) 
and defined a positive test for CAD as one in which a RAZ, 
was present in at least two of these three selected precordial 
leads. Using a group of cardiac-catheterized patients who 
had presented with chest pain but with a normal conven- 
tional 12-lead ECG, the sensitivity and specificity of this 3 
precordial-lead HF QRS ECG test for identifying significant 
CAD (Le., >50% stenosis in a major coronary artery) were 
75% and SO%, respectively. 
Thus, there remains a need for an electrocardiograph that 
analyzes, in real time, the HF components of the entire QRS 
complex in order to provide an effective monitor for patients 
with possible cardiac abnormalities. Further, there remains a 
need for an electrocardiograph that receives the analysis of 
the HF components of the QRS in more than three leads 
(preferably in 12 or more) and automatically and sensitively 
4 
provides a clear and substantially unambiguous indication of 
cardiac abnormalities. The present invention is directed to 
such an electrocardiograph. 
5 SUMMARY OF THE INVENTION 
The present invention addresses these and other needs in 
the art by providing automatic searches for local maxima 
and minima of the QRS envelope according to known RAZ 
i o  criteria and separately according to three additional sets of 
RAZ criteria. The additional RAZ criteria improve the 
overall sensitivity and specificity of detecting CAD, ACS 
and other heart conditions such as cardiomyopathy using 
12-lead HF QRS electrocardiography. The present invention 
15 further provides a real time display of various aspects of the 
QRS complex, including a real-time diagnosis of cardiac 
abnormalities according to the complete set of RAZ criteria. 
The invention also provides a system for such a display, and 
a method of displaying such aspects. The present invention 
20 further parses the HF components of the QRS complex and 
combines spatially related indicators from these data to more 
definitively indicate to the clinician the presence of cardiac 
abnormalities in the patient. The present invention also 
provides a novel display of the related indicators. 
The present invention advances the state of the art by 
taking HF QRS electrocardiographic data immediately as 
they are sensed from a patient, manipulating the data in 
conjunction with the conventional ECG signals, and dis- 
playing the HF data in real time in a useful form on a 
30 computer screen or monitor. In one aspect, the invention 
displays the HF data from the QRS complex in microvolts 
adjacent to a display of the conventional ECG data in 
millivolts. 
In another aspect of the invention, the HF data are 
35 analyzed with software algorithms to determine the presence 
or absence of RAZs. The given RAZ, of which there are at 
least four possible variations (Le., the “Abboud” RAZ 
(RAZ,), “Abboud Percent” RAZ (RAZ,), “NASA” RAZ 
(RAZ,) and the “Kurtosis” RAZ (RAZ,), all described 
40 below), is displayed as a real-time “go, no-go” signal on the 
screen. Finally, in still another aspect of the invention, not 
only the presence or absence any one of the four variations 
of RAZs, but various relations between those RAZs are 
determined to provide a more reliable, immediately visible 
45 indication of possible CAD or other cardiac abnormalities. 
These and other features of the invention will be apparent 
to those of skill in the art from a review of the following 
detailed description along with the accompanying drawings. 
BRIEF DESCRIPTION OF THE DRAWINGS 
25 
50 
FIG. 1 is a trace of a conventional surface ECG in which 
FIG. 2 is a trace of an averaged filtered (150-250 Hz) HF 
FIG. 3 is a trace of an HF QRS signal from the same lead, 
FIG. 4 is a schematic diagram of the overall system of this 
FIG. 5 is a schematic diagram of a detail of FIG. 4. 
FIG. 6 is a schematic diagram of the logic carried out by 
a basic system, prior to the addition of the present invention. 
FIG. 7 is a real-time screen display, showing character- 
65 istic data obtained from a healthy subject, including a 
side-by-side display of a standard ECG and a filtered (HF) 
ECG. 
only LF components are clearly visible. 
QRS limb lead signal from a healthy subject. 
but in a patient with myocardial ischemia. 
55 
6o invention. 
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FIG. 8 is a real-time screen display, showing character- 
istic data obtained from a patient having known cardiac 
disease, including a side-by-side display of a standard ECG 
and a filtered ECG. 
FIGS. 9 and 10 are real-time screen displays, showing the 
configuration of a QRS detector for a normal, healthy 
subject and for a patient having known cardiac disease, 
respectively. 
FIGS. 11 and 12 are real-time screen displays of cross 
correlation between a running, continuously updated signal 
averaged waveform, or template, and a sensed waveform to 
determine departure from the template from one heartbeat to 
the next. 
FIG. 13 is real-time screen display of short term trends of 
various data for another patient having known cardiac 
disease. 
FIG. 14 is a real-time screen display of a “baseline” 
12-lead frequency QRS recording (PRE measurements), 
collected at some time previously, compared to the present 
12-lead high frequency QRS recording (POST measure- 
ments), in a patient who suffered an MI between the two 
time periods. 
FIG. 15 is a schematic diagram of the logic carried out by 
the system with the addition of the present invention. 
FIGS. 16A, 16B, 16C, and 16D are time plots of cardiac 
signals to illustrate the Reduced Amplitude Zone variations 
defined by the present invention. 
FIG. 17 is a time plot of an ECG illustrating rotation of 
the image 180” about the isoelectric (x) axis. 
FIG. 18 is a diagram illustrating the practical equivalence 
of HF QRS signals from the standpoint of RAZ detection 
when rotating the image as shown in FIG. 17. 
FIGS. 19A and 19B are diagrams illustrating what is 
meant by contiguous lead zones in the present invention. 
FIG. 20 is a diagram illustrating the non-equivalence of 
certain precordial and theoretical leads in the present inven- 
tion. 
FIG. 21 is a time plot of low and high frequencies in an 
ECG signal. 
FIG. 22 is an illustration of output displays of the present 
invention. 
FIG. 23 is an illustration of output displays of the present 
invention. 
DETAILED DESCRIPTION OF PREFERRED 
EMBODIMENTS 
To summarize the present invention, in order to visualize 
HF QRS components of ECG signals, the following general 
steps are taken using the system of this invention: First, 
using PC-based ECG hardware and software, properly 
amplified ECG signals are acquired at sampling rates (pref- 
erably 2 1000 samples per second) that are higher than the 
sampling rates used in most traditional digital ECG devices 
(which are typically 5250-500 samplesis). Next, the ampli- 
fied incoming QRS complexes are signal-averaged in each 
receiving channel in order to improve the signal-to-noise 
ratio. Premature complexes and noisy beats are automati- 
cally eliminated (i.e., not added to the running template) by 
a cross correlation function that rejects any individual beat 
that is not adequately cross-correlated to the existing tem- 
plate(s). A cross correlation of at least 97% between the 
incoming beats in each channel and the templates in each 
channel is commonly defined as “adequate”, but this setting 
is user-adjustable. The averaged complexes are then band- 
pass-filtered, preferably in software, using a digital filter that 
passes-frequencies only from 150 to 250 Hz. An example of 
6 
an averaged filtered (150-250 Hz) HF QRS limb lead signal 
from a healthy subject is shown in FIG. 2. The amplitude of 
the signal components in FIG. 2 is in microvolts, whereas 
the scale of the trace illustrated in FIG. 1 is measured in 
Thus, comparing the traces of FIGS. 1 and 2, it is apparent 
that the visible waveform typically offered to the clinician of 
the LF components hides the HF components of the QRS 
waveform, including valuable data regarding cardiac dis- 
ease. For example, FIG. 3 shows an HF QRS signal from the 
same lead as that of FIG. 2, but in a patient with myocardial 
ischemia. Note the reduced voltage scale in FIG. 3 (com- 
pared to FIG. 2), as well as the fact that there are two peaks 
15 7 in the envelope of the HF QRS signal rather than a single 
peak 9 in FIG. 2. A dip 11 in the envelope as indicated in 
FIG. 3 is denoted as a reduced amplitude zone (RAZ). 
A RAZ classically occurs when at least two local maxima 
of the upper envelope or two local minima of the lower 
20 envelope are present within the HF QRS signal. A local 
maximum or minimum is in turn defined as an envelope 
sample point (peak or trough) within the QRS interval 
wherein the absolute value of its voltage exceeds that of the 
three envelope sample peaks immediately preceding and 
25 following it. The RAZ is thus the region lying between the 
two neighboring maxima or minima. The system of the 
present invention automatically searches for local maxima 
and minima of the QRS envelope, not only according to 
known off-line criteria (i.e., “RAZ,”), but also separately 
30 according to three additional sets of RAZ criteria that 
improve the overall sensitivity and specificity for detecting 
CAD, ACS and other heart conditions using 12-lead HF 
QRS electrocardiography, as described in detail below. First, 
however, the basic system for the detection of RAZ and 
35 other criteria indicative of cardiac abnormalities is described 
below. 
Basic System 
5 millivolts. 
FIG. 4 shows a simplified, functional, block diagram of a 
40 real-time HF QRS electrocardiograph 10 constructed in 
accordance with the present invention. The invention moni- 
tors the cardiac function of a patient with a plurality of 
patient electrodes 12. The electrodes provide measurements 
of cardiac electrical function at various contact points on the 
45 skin of a patient in the conventional manner. For example, 
in the conventional 12-lead configuration, 10 electrodes 
placed upon the skin of the patient in the conventional 
configuration result in eight channels of incoming data. 
These eight channels are in turn translated into 12 leads of 
50 data on the patient monitor inasmuch as data for one of the 
bipolar limb leads and for all of the augmented unipolar limb 
leads can be derived if data for any two of the bipolar limb 
leads are already known. The analog measurements are 
coupled to a console 14 by way of a communications 
55 channel such as for example a cable 13. The console 
components are shown in greater detail in FIG. 5. 
The console 14 conditions and digitizes the analog signal 
and provides the digitized signal to a computer 16 by way of 
a communications channel 15, which may preferably be a 
60 conventional cable or a wireless communication channel by 
radio frequency wave. The structure and function of the 
computer is shown and described below in respect of FIG. 
6. The computer 16 is programmed to display the ECG 
signal in real time, although the ECG signal may also be 
65 stored on a digital recording medium 18 over a communi- 
cations channel 17 for later display over a communications 
channel 17’. 
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The computer 16 is coupled to a user interface 20 which 
preferably includes communications devices 22 such as a 
mouse, keyboard, andor touch screen. The user interface 
further includes a monitor 24 for user controllable graphic 
display of the ECG and various aspects of the signal, a 
feature of the present invention. The computer 16 is coupled 
to the interface 20 by way of bidirectional communications 
channels 19 and 19’, for example. The aspects of the 
graphical display are shown in greater detail and described 
below in respect of FIGS. 7 through 23. 
FIG. 5 depicts the structure of the console 14 in greater 
detail. As previously described, the patient is wired with a 
set of electrodes 12, such as for example a conventional set 
of ten electrodes for a 12-lead electrocardiograph to monitor 
cardiac function from different aspects of the patient’s body. 
The electrodes 12 provide a set of analog electrical signals 
to the console 14, where the signals are received by a 
pre-amplifier 30 to boost their amplitude. The amplified 
signals are then fed to an anti-aliasing filter 32 having an 
appropriately high low-pass characteristic. The filtered sig- 
nals are then fed to an analog to digital converter 34, where 
the signals are digitized at at least the Nyquist rate, prefer- 
ably 1,000 Hz or greater, to retain all of the information 
contained in the analog signals. The sampleddigitized sig- 
nals are then sent to the computer 16 by an appropriate 
medium 15. 
The operation of the computer 16 is depicted in FIG. 6. 
The console 14 feeds the digitized ECG signals to the 
computer via a communications channel 15, as previously 
described. The computer 16 also interfaces with the user 
interface 20. The computer 16 receives the ECG signals into 
a device driver 40, which is simply the interface device and 
program for the console and computer. The device driver 40 
provides the ECG signals in parallel to an R-wave detection 
block 42 to synchronize the system for the start of each 
heartbeat by locating the fiducial point. The following 
requirements must be met for temporal averaging to work 
effectively. First, the signal of interest must be repetitive and 
relatively invariable. Time varying signals, such as ectopic 
or premature complexes, are eliminated before averaging by 
comparing incoming signals against previously established 
templates through the use of a real-time cross-correlating 
technique. Second, the signal of interest must be timelocked 
to a fiducial point, such as near the peak of the QRS 
complex, that is easily detectable and serves as a timing 
reference for the averaging algorithm. If the signal of 
interest does not have a fixed, temporal relationship with the 
timing reference point, the resultant averaged signal will be 
filtered and distorted due to reference jitter, with subsequent 
loss of the HF components. Third, the signal of interest and 
the noise must be independent and remain independent 
during averaging. 
Once the fiducial point has been located for each incom- 
ing beat, the digitized signals are fed to block 44 where 
initial templates of the QRS complexes are generated. The 
present invention includes running signal averages of the 
QRS complexes that constitute templates in each lead, with 
the number of individual beats in the running templates 
being selectable by the user on the user interface 20. The 
user can also determine the percent of cross-correlation 
between each new incoming beat and the templates which 
will be detected as a departure from the norm, and which 
channel(s) that will be used for the cross-correlation func- 
tions. 
With the user-selected inputs as just described, the system 
in block 48 runs a real-time cross-correlation function on 
each subsequent incoming beat. In block 50, those beats 
8 
which are below the threshold set by the user (or set by the 
system default) are rejected, with block 52 accepting only 
well-correlated beats to create the running templates. This 
feature helps to eliminate noisy, unreliable waveforms when 
5 creating the running templates. From this block, the user 
interface displays a continuously updated running total of 
the number of beats accepted and rejected in block 51, a 
feature of the invention. 
Block 54 then aligns the beats in each channel by detect- ’’ ing and adjusting for any signal jitter, which may be created 
by any number of well-known factors, including minor 
inconsistencies in the detection of the fiducial point, move- 
ment by the patient or even respiration by the patient. The 
aligned, jitter-corrected waveforms are then fed to block 56, 
l5 a band-pass filter, preferably 150-250 Hz, to select only the 
frequencies of interest in the waveform. Finally, the band- 
pass signals are fed to block 58, where, in the present 
embodiment, the eight channel to 12-lead conversion is 
performed. 
From this point in the diagram of FIG. 6, blocks 62, 64, 
68, 70, and 72 describe data which are displayed on the user 
interface 20, as shown in FIGS. 7 through 23. Block 62 
shows the instantaneous, real-time filtered HF QRS signal 
for each lead, updating with each new beat as that beat is 
incorporated into the average beat. Beats that are poorly 
cross-correlated are rejected and thus the template averages 
and the display will not be altered by such beats. The display 
is shown by element number 114 in FIG. 7. 
Block 64 determines the unfiltered QRS interval onset and 
offset automatically and in real time. This block receives an 
input from block 54 which detected and adjusted for any 
jitter in the well cross-correlated beats. The cross-correlation 
and jitter-correction from block 54 are therefore also dis- 
35 played on the user interface, as shown in FIGS. 11 and 12. 
Block 68 describes the display of certain instantaneous 
measures of HF QRS amplitude, including the root mean 
square (RMS) voltage, the high frequency energy (HFQE) 
and the high frequency integral of absolute value (HFAV) 
40 generated for each lead using the unfiltered QRS interval 
onset and offset. The measures of amplitude are mathemati- 
cally defined hereinafter, whereas the unfiltered QRS inter- 
val onset and offset are shown in FIG. 7 as element numbers 
116 and 128, respectively. 
Block 70 describes the running plots of the RAZs (“go/ 
no-go”) as well as the voltages for the RMS, HFQE and 
HFAV of the HF QRS ECG signal versus time for each lead 
as depicted in FIG. 13. FIG. 13 depicts short-term data in a 
patient with known CAD wherein the horizontal (time) axis 
50 scale is user-adjustable and can be shown either in total or 
accepted beats (the latter being depicted here) or in seconds. 
Clinicians can utilize these trends to assess how a monitored 
patient’s cardiac function has changed over time, up to and 
including the present time. Specifically, clinicians can iden- 
55 tify whether and when RAZs have developed or disappeared 
during the period of monitoring, as well the degree to which 
the RMS and related voltages of the HF QRS complex have 
changed over the same period of monitoring. Realization of 
such changes is particularly valuable to clinicians during 
60 situations when the presence or absence of incipient myo- 
cardial ischemia or infarction needs to be immediately 
identified, when the success or failure of invasive or non- 
invasive treatments administered for ischemia and infarction 
needs to be immediately recognized, andor when cardio- 
65 vascular responses during pharmacological or exercise 
stress tests or during a patient’s ambulatory activities needs 
to be assessed. 
20 
25 . 
30 
45 
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Finally, block 72 describes another feature of the inven- figuration in order to facilitate judgments regarding lead 
tion, online instantaneous RAZ detection for each lead. The contiguity. The user is given the option of using the CR 
presence of a RAZ within the envelope of the averaged HF leads, wherein the reference for the precordial signals is the 
QRS signal may be an indication of abnormal cardiac right arm electrode rather than Wilson’s central terminal, 
function. As noted above, a RAZ, as originally defined by 5 because the CR lead configuration results in larger absolute 
Abboud (but only in the context of off-line analyses), QRS voltages than the V precordial lead configuration, 
classically occurs when at least two local maxima of the potentially enhancing HF QRS diagnostic sensitivity. Fur- 
upper envelope or two local minima of the lower envelope ther, the display of the conventional signal average 112 is 
are present within the HF QRS signal. A local maximum or updated with each beat, as a reference for the clinician. 
minimum is in turn defined as an envelope sample point i o  Positioned immediately adjacent to or below the conven- 
(peak or trough) within the QRS interval wherein the tional ECG display 112 is a display 114 of a running, 
absolute value of its voltage exceeds that of the three instantaneous filtered (Le. HF) QRS ECG signal, one for 
envelope sample peaks immediately preceding and follow- each of the twelve leads, corresponding to the individual 
ing it. The RAZ is thus the region lying between the two leads of the display 112. The display signal 114 includes the 
neighboring maxima or minima. The present invention per- 15 signals from leads I, 11, 111, aVR (or -aVR), aVL, aVF, and 
forms a real-time calculation, looking for local maxima and V1 -V6 (or CR1 -CR6) to correspond to like signals in the 
minima of the QRS envelope not only according to previ- display 112. Above each HF QRS signal are the instanta- 
ously published off-line criteria ofAbboud (Le., “RAZ,”, or neous RMS and kurtosis values 116 and 116’, respectively, 
the Abboud RAZ) but also separately and especially accord- in that particular lead, and an instantaneous RAZ indicator 
ing to new criteria that improve the accuracy of 12-lead high 20 117, color-coded to indicate the RAZ type(s) that are actu- 
frequency QRS ECG for use in cardiac diagnoses in both the ally present. 
offline and online settings. At the bottom of the screen display of FIGS. 7 and 8 is a 
One especially important modification contributing to tool bar 120. The tool bar 120 provides user control and 
such improvement is the requirement, as shown in FIGS. display of various data useful to the clinician. The tool bar 
16C and 16D, that in order to constitute a stricter type of 25 includes a user selectable indicator 122 in which the user can 
RAZ, the absolute value of the amplitude of the smaller of select which of a plurality of QRS complexes will be used 
the two local maxima (or minima) must be at least a certain to define the unfiltered QRS interval(s). Displays 124, 126, 
percentage of that of the larger of the two local maxima (or and 128 show the timing of the QRS onset, QRS offset, and 
minima). When a RAZ, is present and at least one secondary the duration of the QRS complex, respectively. A display 
local maximum (or minimum) also meets this “minimum 30 130 shows the total number of heartbeats which have been 
relative amplitude” requirement, then an “Abboud Percent” detected during any particular recording, while a display 132 
RAZ, or RAZ,, is also said to be present (FIG. 16C). When shows the number of beats rejected and a display 134 shows 
a RAZ is present and at least one secondary local maximum the number of beats whose processing is pending, if any. 
as well as at least one secondary local minimum both meet Toggle buttons 136 and 138 permit the user to turn on and 
this “minimum relative amplitude” requirement, then a 35 turn off the cross correlation function and the beat rejection 
“NASA RAZ”, or RAZ,, is also said to be present (FIG. function, respectively. Display buttons 140, 142, 144, and 
16D). 146 permit the user to select other displays for the screen, as 
Yet another novel set of user-selectable criteria used in the shown. A toggle button 148 permits the user to turn on and 
present invention to assess the presence or absence of a turn off an autoscale function, and a print button 148 permits 
“statistical” type of RAZ concerns the use of real-time 40 the user to print a particular screen capture at his discretion. 
calculation of the kurtosis of the incoming HF QRS signal. Of particular note, in comparing FIGS. 7 and 8, is the 
When present, the kurtosis type of RAZ is referred to as the small number of RAZs and lit RAZ indicators 117 for the 
RAZE The presence of a RAZ,, RAZ,,, RAZ,, andor healthy patient shown in FIG. 7, versus the much larger 
RAZ, by “goino-go” indicators on the display, as shown by number of RAZs and lit RAZ indicators for the subject with 
element 117 in FIG. 7, may also be displayed as a running 45 known CAD, shown in FIG. 8. 
parameter with time, in a manner similar to FIG. 13. FIGS. 9 and 10 show configuration screen 160 for the 
Referring now more particularly to FIGS. 7 and 8, a online QRS interval detector of the invention, selectable by 
feature of the present invention is the simultaneous display button 146 of FIGS. 7 and 8. The configuration screen of 
in real-time of various aspects of cardiac function with FIGS. 9 and 10 permits the user to select a period within the 
respect to both the conventional and HF QRS ECG. Further, 50 P-R interval of the ECG, with specific pre-Q offset and 
the present invention provides simultaneous, side-by-side or interval width selectors 162 and 164, respectively, that will 
vertical displays of that data to provide the clinician with a aid in the determination of the onset of the QRS complex. 
tool to compare these aspects of the ECG with one another The values for these parameters shown in FIGS. 9 and 10 
for a more complete picture of cardiac function than has have been selected based on initial experience to provide 
been previously available. The present invention also dis- 55 satisfactory performance of the invention for the broadest 
plays the conventional and HF QRS 12-lead configurations array of subjects, since cardiac function typically varies 
on one user interface display, while displaying the presence from patient to patient. Similarly, selectors 166 and 168 
or absence of RAZs on the same display to alert the clinician permit the user to select the offset and width, respectively, of 
to potentially abnormal cardiac function. a portion of the ST segment that will aid in the determination 
The display of FIGS. 7 and 8 includes a conventional, 60 of the offset of the QRS complex. The configuration screen 
signal-averaged ECG signal, designated by the element 160 also displays various parameters measured from the 
number 112. The display signal 112 includes the signals current heartbeat, as shown. An indicator 170 shows the user 
from leads I, 11,111, aVR, aVL, aVF, displayable in either the which of the leads is selected, in the case of FIGS. 9 and 10 
conventional or sequential (Le., aVL, I, -aVR, 11, aVF, 111) that lead is lead 11. A RAZ indicator 117 is also provided for 
configuration, and the signals from either precordial leads 65 the convenience of the user. 
V1 -V6 or precordial leads CR1 -CR6. The user is given the FIGS. 9 and 10 also include superimposed displays of a 
option of displaying the limb leads in the sequential con- conventional QRS signal average 172 and its associated 
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averaged filtered (HF) QRS signal 174. The ordinate on the 
left of FIGS. 9 and 10 shows the averaged conventional 
signal 172 in millivolts, and the ordinate on the right shows 
the averaged HF signal 174 in microvolts. 
FIG. 9 shows a single local maximum 176 and a single 
local minimum 178. However, FIG. 10, depicting the wave- 
forms for a patient with known CAD, shows two local 
maxima 180 and 182, and two local minima 184 and 186. 
Since the maxima andor minima occur within the QRS 
complex, and are separated by at least three envelope sample 
points with lesser absolute amplitudes between them, they 
define a reduced amplitude zone as also shown on the lit 
RAZ indicator 117. 
FIGS. 11 and 12 depict cross correlation screens 190 of 
the invention. This display may be referred to as the cross 
correlation panel. The screen 190 is selected by a user with 
button 144 (FIG. 7). The screen includes a display 192 of a 
conventional QRS signal average (Le., any one of the 
multiple QRS templates being derived), averaged over a 
user selectable number of beats. A display 194 shows the 
conventional QRS complex of the current incoming beat, 
and a display 196 shows the cross correlation between the 
waveforms of display 192 and display 194. A user may 
select the threshold for the cross correlation, below which 
the beat is rejected, by a selector 197 and, if a beat is 
rejected, an indicator light 198 illuminates. A digital display 
191 on the right side of the cross correlation panel shows 
both the instantaneous and the summarized cross-correla- 
tions for all channels simultaneously. This digital display 
also updates from one beat to the next. Moreover, the user 
can use this digital display to troubleshoot observed exces- 
sive rejections of beats. In other words, the display 191 
allows the user to determine which leads or channels contain 
the most rejected beats, and in turn to physically adjust those 
leads most affected by rejected beats in order to proceed with 
an overall less noisy recording. The display 191 further 
provides instantaneous cross-correlation and R-wave jitter 
correction of the new beat versus the template beat in each 
individual channel, and a mean cross-correlation of all beats 
in a channel so far versus the templates that have existed for 
that channel, as shown in FIG. 11. 
Note that the display 191 provides a visual display of the 
instantaneous and past cross-correlations within all eight 
channels simultaneously, another feature of the present 
invention. Further, the display 196 depicts the cross-corre- 
lation function and jitter correction of all eight channels on 
a single display, preferably with each function in a different 
color. The panel 190 also includes a user-selectable thresh- 
old 195 permitting the user to select rejection based on how 
many channels fail correlation, shown in FIG. 11 as set to 
“l”, such that any beat rejected in any channel gets rejected 
in all channels. 
Note also that in FIG. 12 the current heartbeat shown on 
the display 194 is noisy and has a different shape than the 
template. The current beat is also shifted in time from the 
template of display 192. Consequently, the cross correlation 
between them is poor, as reflected in the display 196, which 
only has a peak of 0.958 (Le. below the user selectable 
threshold set at 0.970 in this case) and the beat is rejected, 
as shown by the indicator light 198. Thus, the current beat 
is not incorporated into the running templates of the aver- 
aged ECG. 
By comparing the displays in FIGS. 11 and 12, one can 
see that the patient whose cross-correlation is shown in FIG. 
11 has had roughly 30% of the beats rejected, mostly 
because of poor cross-correlation in channel I. One the other 
hand, in FIG. 12, 81 3% of the beats have been rejected due 
12 
to poor cross-correlations in several different channels, 
suggesting an overall poor preparation of the electrodes or 
some other more global source of noise. 
FIG. 13 depicts trend lines for the RMS, HFQE, HFAV 
5 and kurtosis, and shows the current value for these param- 
eters, for a patient with known heart disease. This display 
further includes lines depicting the presence versus the 
absence of the RAZ,, RAZ,, and RAZ,as described herein. 
This display illustrates another feature of the present inven- 
10 tion, that of showing a trend of parameters over time. 
Specifically, the trend lines shown on a screen 200, which 
are continuously updated in real time, illustrate the presence 
(versus the absence) of all defined types of RAZs over a 
user-selectable period of time (always up to and including 
15 the present time) as well as the trends for RMS, HFQE, 
HFAV and kurtosis over this same user-selectable period of 
time for all the leads attached to the patient. A similar but 
longer-term trend line plot can also be generated (for 
example with thousands of beats rather than hundreds of 
20 beats on the x axis), and the short and long-term trend line 
plots can be accessed simultaneously by the user. To reiter- 
ate, the time intervals (horizontal axes depicted here in units 
of beats) on any of these plots are completely selectable by 
the user. The particular parameters depicted on the plot 
25 shown are intended to be illustrative only, and other param- 
eters may be similarly illustrated. The ordinate for each plot 
is in microvolts with respect to the RMS, HFQE and HFAV 
and is unitless for kurtosis. (The RAZs are also unitless, 
being “go versus no-go” entities). The abscissa can be in 
30 either beats or seconds, for characterization of the trend. 
FIG. 14 illustrates another feature of the present inven- 
tion. FIG. 14 depicts a display 250 which plots a baseline 
12-lead HF QRS recording 252, such as for example, a 
pre-angioplasty recording, juxtaposed with a current, 
35 dynamic QRS display 254. The display 250 further includes 
a ARMS reading 256 and a AKurt (Akurtosis) reading 258, 
to dynamically display the differences between the baseline, 
or “pre-procedure” readings, and current, or “post-proce- 
dure” readings for comparison. This feature can also provide 
40 an indicator of gain or loss of any type of RAZ between the 
two time points. The tracings shown for illustration purposes 
are for a patient who suffered an angioplasty-induced MI 
between the baseline 252 and current 254 time points. 
Numerical measures of the HF QRS ECG may be calcu- 
45 lated in several ways. These measures are important because 
they often decrease when ischemia is present. Perhaps the 
most popular measure is the root mean square (RMS) 
voltage of the QRS signal, which is equivalent to the “area 
under the curve” of the power spectrum, defined as 
50 
55  
where X, is the filtered voltage at a given sampling point, 
ufqon and ufqoff are the onset and offset, respectively, of the 
60 QRS interval, and UFQRSD is the unfiltered QRS interval 
duration as defined by ufqon and ufqoff. In this context, the 
term “onset” means the start of the QRS interval, and the 
term “offset” means the end of the QRS interval. This is the 
primary numerical measure used in preferred embodiment of 
Other numerical measures of the HF QRS signal have also 
been proposed (and used strictly in an off-line fashion) by 
6 5  the present invention. 
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Xue et al. (see Xue, Q., B. R. Reddy, and T. Aversano. 
Analysis of high-frequency signal-averaged ECG measure- 
ments. JElectrocardiol28: 239-45, 1995). These numerical 
measures include the high frequency integral of absolute 
values (HFAV) and the high frequency QRS energy (HFQE). 
Xue et al. have defined HFAV and HFQE as follows: 
wherein AVNL equals the average noise level of the filtered 
signal in the ST segment in a 40 ms window located 60 ms 
from the QRS offset. It should be noted that in their own 
definitions for HFAV and HFQE (as shown above), Xue et 
al. “pad” both the QRS onset and offset by extra 10 ms each 
in an effort to reduce noise and noise variability, presumably 
to compensate for potential inaccuracies and inconsistencies 
related to the determination of the QRS interval. 
In the presently preferred embodiment of the invention, 
the definitions for HFAV and HFQE are modified in two 
ways. First, because the present invention provides a means 
of viewing the high and low frequency ECG signal in real 
time, thereby providing reliability for the determination of 
the QRS interval, the necessity (or lack thereof) of using the 
10 (or alternative) millisecond padding periods is left to the 
discretion of the user. Second, the present invention prefer- 
ably uses the PR interval or TP segment rather than the ST 
segment to determine the AVNL of the baseline, since a 
segment of the cardiac cycle wherein neither myocardial cell 
depolarization nor repolarization is occurring is preferred. In 
the device of the present invention disclosed herein, AVNL 
is determined as the RMS noise of the filtered signal that is 
within a 25 ms interval in the PR segment. 
In a preferred embodiment, HFAV is measured as: 
wherein AVNL (average noise level) equals the “noise” of 
the high frequency (i.e., filtered) signal within that portion of 
the PR interval just noted and UFQRSD is unfiltered QRS 
duration. 
Further, high frequency QRS energy (HFQE) is calculated 
as: 
wherein AVNL is determined in the same way as for HFAV. 
A useful characterization of a set of data includes skew- 
ness and kurtosis. Skewness is a measure of symmetry, or 
more accurately, the lack of symmetry. A distribution, or 
14 
data set, is symmetric if it looks the same to the left and right 
of the center point. Kurtosis is a measure of whether the data 
are peaked or flat relative to a normal distribution. That is, 
data sets with a high kurtosis tend to have a distinct peak 
5 near the mean, decline rather rapidly, and have heavy tails. 
Data sets with low kurtosis tend to have a flat top near the 
mean rather than a sharp peak. A uniform distribution would 
be the extreme case. By determining the skewness and 
kurtosis of individual HF QRS signals, and by displaying the 
skewness values alone, the kurtosis values alone, or skew- 
ness versus kurtosis graphically with one value on the 
ordinate and the other on the abscissa, the clinician may 
obtain information from the HF QRS signals potentially 
15 indicative of cardiac disease. This is described in further 
detail below with respect to the currently preferred embodi- 
ment. 
Currently Preferred Embodiment 
As previously described, additional sets of RAZ criteria 
improve the overall sensitivity and specificity of detecting 
CAD, myocardial ischemia and infarction and other heart 
conditions using 12-lead HF QRS electrocardiography. The 
logic illustrated in FIG. 15 is the same as that previously 
25 described in respect of FIG. 6, with the exception of an 
additional automatic diagnosis component 300, and the 
previous description FIG. 6 is incorporated here as if 
repeated, but is omitted here for brevity. The automatic 
diagnosis component 300 receives signals regarding RAZs 
30 from the instantaneous RAZ detector 72, as previously 
described. 
To describe the analysis performed by the component 300, 
a series of ECG signals are depicted in FIGS. 16A through 
16D. FIG. 16A illustrates an example of a “normal” HF QRS 
35 complex, in which no RAZ has been detected. FIGS. 16B 
through 16D illustrate “abnormal” HF QRS complexes in 
which RAZ types of ascending severity have been detected 
through use of additional criteria analyzed by the component 
300. The envelope of the HF QRS signal in FIG. 16B has 
40 both a primary local maximum and a secondary local 
maximum. ARAZ, is therefore present. (The same envelope 
also has a primary local minimum and a secondary local 
minimum, which too are sufficient to form a RAZ,). How- 
ever, the requirement that the voltage of any secondary local 
45 maximum on the envelope be at least X% of that of the 
primary local maximum, or that the voltage of any second- 
ary local minimum on the envelope be at least X% of that of 
the primary local minimum, has not been met by the signal 
in FIG. 16B. In the system software as presently preferred, 
50 X% tentatively defaults to 30%, based empirically upon data 
collected from individuals with and without CAD, but the 
percentage is user-adjustable and can be changed at any time 
to suit the specific diagnostic need or population being 
studied. When a RAZ, is present and its secondary local 
55 maximum (or minimum) meets this “X% (e.g., 30%) or 
more of the primary local maximum (or minimum)” addi- 
tional requirement, then an “Abboud Percent” RAZ 
(RAZ,,) is also said to be present. This defined RAZ,, is 
illustrated in FIG. 16C as RAZ 301. Furthermore, when two 
60 local maxima of an upper envelope 304 and (rather than or) 
two local minima of a lower envelope 306 are present within 
the HF QRS signal, and when both the secondary local 
maximum and the secondary local minimum meet the “X% 
(e.g., 30%) or more of the primary local maximum (mini- 
65 mum)” additional requirement, then a very strict type of 
RAZ known as the “NASA RAZ” (“RAZ,”) is also said to 
be present, shown as RAZ 302 in FIG. 16D. 
I U  
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FIGS. 16Athrough 16D are screen snapshots showing HF value noted here for kurtosis is given strictly to provide an 
QRS complexes below their respective signal-averaged con- illustration of the spirit of the use of kurtosis in present 
ventional QRS complexes 310. The darkened circular points innovation. Similar to the RAz, percentage cut-off values, 
312 in the HF QRS signals connote envelope local maxima the exact kurtosis cut-off values ultimately utilized for 
and minima, whereas arrows, when Present (FIGS. 16B 5 clinical purposes are subject to change based upon several 
through 16D), connote a RAZ. factors, including but not limited to the specific cardiac 
In 16A, an HF QRS from lead I is shown condition that one is attempting to diagnose; the exact 
that contains no RAZs. This complex is “normal”. In FIG. number of beats that are in the signal average; the specific 
16B, an HF QRS from lead aVF contains an channel or channels being used to provide the HF QRS ECG 
portions or envelopes of the signal. The amplitudes of both specific version of the ECG hardware or analysis software 
the secondary local maximum and minimum are nonetheless being used (i,e,, type of R-wave detector being utilized, 
because they are less than 30% (empirically defined) of the 
amplitudes of their corresponding primary local maximum 15 When the presence Or absence Of a RAzN, RAzA,, RAzA 
aVR has a RAz, 301, The RAz, is present because the of 10 ms is also preferably included on both sides of the QRS 
absolute amplitude of the secondary local maximum (left interval, because such padding reduces noise and noise 
side of that forms the RAz is 230% of that of the variability while also compensating for any potential inac- 
2o curacies andor inconsistency related to the determination of corresponding primary local minimum. 
Finally, in FIG, 16D, an HF QRS signal has a “NASA the QRS interval duration. In the present invention, the 
(RAzN) 302, A RAzN is present because both a skewness (a statistical determination of a lack of symmetry) 
secondary local maximum and a secondary local minimum of the individual HF QRS signals is also measured. 
are present and both have amplitudes exceeding 30% of the As previously described, it is known in the art, using 
amplitudes of their respective primary local maximum/ 25 off-line analysis, to employ Only three of the &mdard 12 
minimum, Note that whenever a u z N  is present in any ECG lead positions and to define a positive test for CAD as 
given HF QRS complex, a uz ,  and u z ,  must also be one in which a RAZ, is present in at least two of these three 
present by definition, and similarly whenever a uz,, is selected precordial leads. The present invention, however, 
present, a RAZ, must also be present by definition. uses a set of 12-lead HF QRS ECG criteria, thereby pro- 
already noted, another novel set of criteria used in the 30 viding an ability to more sensitively and specifically identify 
innovation to the presenceiabsence of CAD and other heart conditions. 
type o fRAz  the calculation ofthe kurtosis ofthe The 12-lead criteria will now be described in detail. 
incoming HF QRS signal. In the presently preferred embodi- All included criteria listed below are based on multi-beat 
ment, to determine the kurtosis of an HF QRS signal in real signal averaged ECG recordings that have acceptable signal- 
time, the absolute value in microvolts of the envelope 35 to-noise ratios (generally requires 250  beats) and that use 
sample points is plotted against time in milliseconds. The the results of cross-correlation in any one or more of the 
resulting figure, when normalized to have an area of 1 .O, can ECG channels as the criterion for individual beat acceptance 
be thought of as a probability density function with central versus rejection. A given RAZ can be considered present 
moments pk=J(t-p)kf(t)dt (k=l, 2, . . . ), where f(t) is the either when it occurs during at least X% (preferably 50%) of 
normalized absolute voltage at sample point t and p=Jtf(t)dt. 40 all (or some portion of) the accepted beats constituting the 
The kurtosis (y) is the normalized fourth moment recording (preferably the entire recording, but a user-adjust- 
able portion may be used). Alternatively, a RAZ can be 
considered present when it occurs at only at the very end of 
the recording, when the signal-to-noise ratio is at its greatest. 
In one aspect, the present invention defines a set of criteria 
indicative of CAD or an ACS, as determined by the appa- 
ratus described above. When complicating cardiac condi- 
Because a bimodal distribution has a relatively low kurtosis, tions such as bundle branch blocks, heart failure, ventricular 
and because the Presence Of a RAz the Of hypertrophy, extreme axis deviation, paced rhythms and 
an HF QRS envelope to resemble a bimodal distribution, HF 50 arrhythmias are not present, then a multi-beat 12-lead HF 
QRS signals With RAzS typically have a low kurtosis. BY QRS ECG recording with a sufficient signal-to-noise ratio is 
applying the statistical concept of kurtosis to an HF QRS suspicious for CAD or an ACS when: 
signal itself, mathematically more robust information con- 1) A RAzN is present in each of three or spatially 
contiguous HF QRS ECG leads; or, cerning the shape of the HF QRS signal may be obtained than from other measures such as the RAZ,. At the present 55 
time, the software automatically separates the kurtosis char- 2, A RAzA, RAz, is present in each Of four Or 
more spatially contiguous HF QRS ECG leads, or acteristic of each HF QRS signal into “normal” and “low” 
categories. An individual HF QRS ECG signal having a 3 )  A  ZAP andor RAZK is Present in each of five Or 
kurtosis value of greater than 2.65 is presently designated as more total HF QRS ECG leads when the five or more 
RAZ” (RAZ,) present within it. On the other hand, a HF two or more spatially contiguous limb leads plus in 
QRS signal with a kurtosis value of less than 2.65 is three or more spatially contiguous precordial (i.e., V or 
presently designated as “abnormal”, and is considered to CR) leads, andor in b) three or more spatially contigu- 
have a RAZ, present within it. The presence of a RAZ, is ous limb leads plus in two or more spatially contiguous 
important because, as will be explained in greater detail 65 Precordial 6% v Or CR) leads. 
below, the RAZ, and the RAZ,, are often considered Cases 2) and 3) are specific cases wherein RAZ, and 
interchangeable from a diagnostic standpoint. The cut-off RAZ,, are considered diagnostically interchangeable. That 
“Abboud 
(RAzA) On both the right upper and lower lo cross correlation template(s) for beat rejection; and the 
insufficient to define an “Abboud Percent” RAz (RAzAP), degree of jitter present in the R-detector, etc,), 
and minimum, In FIG, 16C, an HF QRS complex from lead RAzK is in the system Of 15, a “pad” 
the presence or absence ofa  
y =  w -
P: ’ 45 
“normal” with respect to kurtosis-i,e,, it has no “kurtosis 60 affected leads are distributed as  follow^: Either in: a) 
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is, the RAZ,, and RAZ, can substitute for one another in 
any mixed combination toward fulfilling either of these 
case’s criteria. 
“Spatial contiguity” is defined somewhat differently when 
identifying RAZs in the context of 12-lead HF QRS elec- 5 
trocardiography than when identifying potential ischemic 
provided that can be derived from either precordial lead test conventional electrocardiography. The reason for this configuration for 12-lead HF QRS electrocardiography: difference is demonstrated in FIGS. 17 and 18. leads Vl-V5 and leads V2-V6 (or leads CR1-CR5 and leads 
When conventional lead a VR is flipped 180” about its x CR2-CR6), 
(isoelectric) axis (upper left side of FIG. 17), it becomes As shown in FIGS. 19A and 19B, when the six frontal conventional lead-aVR, and the frontal plane vector it plane leads are plotted together with their respective coun- reflects changes from +210° (aVR) to +30° (-aVR) (as terparts that are 1 SO” away in frontal plane, the 12 resultant shown in FIG. 18). However, when the HF QRS tracing leads form a circle with increments at every 30” in the from the same lead is flipped in the same fashion (upper l5 frontal plane (FIG. 19A). The resulting lead “zones” that can right side of FIG. 17), even though the frontal plane vector be derived from this (FIG. 19B) are used in the present changes similarly, any RAZ that is present (or absent) prior invention in the following specific fashion: When RAZ+ to the flipping will always remain present (or absent) after are present in at least three contiguous HF limb lead zones 
as shown in FIG. 19B (for example, in HF QRS leads 111, the flipping. Thus, strictly from the standpoint of detecting 
aVL, and I simultaneously, or in HF QRS leads aVL, I11 and RAZs in HF QRS tracings, lead aVR is equivalent to lead 2o -aVR. Furthermore, this same concept of practical equiva- aVF simultaneously, as described above), or when RAZ,,s lence with respect to RAZ detection also applies to all of the andor R A Z s  are present in at least four contiguous HF other limb leads and their respective counterparts located limb lead zones as shown in FIG. 19B (as described above 180” away in the frontal plane. in respect of the six possible combinations of “four contigu- 
RAZ detection, therefore located both at +30° degrees and positive 12-lead HF QRS ECG tracing for CAD or ACS, 
at +210° in the frontal plane, it is therefore spatially con- assuming that other potentially complicating conditions are 
tiguous to (i.e~> Only 30 degrees away from) the not present simultaneously. Some of these other potentially 
located both in lead I (+O” in the frontal plane axis) and lead 3o complicating conditions include a QRS interval ,120 ms, 
heart failure due either to cardiac systolic dysfunction (i.e., I1 (+60° in the frontal plane axis). 
Furthermore, as can be construed from FIGS. 19A and low ejection fraction) or diastolic dysfunction, left ventricu- 
19B, there are therefore six sets of “three contiguous leads” lar hypertrophy, atrial fibrillation, flutter or other atrial or 
that can be derived from the six frontal plane leads for use ventricular arrhythmias, prior pacemaker insertion, and 
in RAz detection in 12-lead HF QRS electrocardiograPhY. 35 Wolff Parkinson White or other pre-excitation syndromes. 
These are: As shown in FIG. 20, individuals with R A Z d  present in 
at least three contiguous precordial leads (e.g. Vl-V3 or 
CR1-CR3 and similar combinations), or RAZ,,s andor 
R A Z s  present in at least four contiguous precordial leads 
40 (e.g., V2-V5 or CR2-CR5 and similar combinations) are also 
judged to have a 12-lead HF QRS ECG tracing positive for 
CAD, assuming that no other potentially complicating con- 
ditions or factors are present. However, with respect to the 
detection of RAZs in the precordial leads, the 1 SO” mirror of 
Sets 0f‘‘foUr COntigUOUS leads” that can be derived from the 45 precordial lead V1 in the horizontal plane (i.e., a theoretical 
six frontal plane leads: “minus V1” lead) may not be a positional equivalent of a 
theoretical V7 lead, and so RAZs in V6 and V1 (or in CR6 
and CR1) may not be construed as contiguous for the 
purposes of 12-lead HF QRS diagnoses. Nonetheless, from 
50 FIG. 20, it should be apparent that RAZs in contiguous 
precordial leads V1 -V3 may indicate posterior myocardial 
coronary insufficiency rather than (or in addition to) anterior 
myocardial coronary insufficiency, depending upon the spe- 
as well as three sets of “four contiguous precordial leads” for 
each configuration: 
set l=leads Vl-V4 (or CR1-CR4); 
set 2=leads V2-V5 (or CR2-CR5); and 
set 3=leads V3-V6 (or CR3-CR6). 
changes in the context of 12-lead resting or exercise stress sets Of “five precordia’ leads” are 
Because HF QRS lead aVR is, from the Perspective Of 25 ous limb leads”), then that individual is judged to have a 
set l=leads 111, aVL and I; 
set 2=leads aVL, I and aVR; 
set 3=leads I, aVR and 11; 
set 4=leads aVR, I1 and aVF; 
set 5=leads 11, aVF and 111; and 
set 6=leads aVF, I11 and aVL. 
Referring again to FIGS. 19A and 19B, there are also Six 
set l=leads 111, aVL, I and aVR; 
set 2=leads aVL, I, aVR and 11; 
set 3=leads I, aVR, I1 and aVF; 
set 4=leads aVR, 11, aVF and 111; 
set 5=leads 11, aVF, I11 and aVL; and 
set 6=aVF, 111, aVL and I 
cific clinical circumstances. 
The following discussion pertains to situations in which 
RAZ,, andor RAZ,, when present in certain combinations 
of limb leads plus precordial leads, can constitute a positive 
test for CAD or ACS. When using conventional electrocar- 
as well as six sets of “five contiguous leads” that can be 
derived from the six frontal plane leads in a similar fashion: 55 
set l=all frontal plane leads except lead 111; 
set 2=all frontal plane leads except lead aVL; 
set 3=all frontal plane leads except lead I; and so forth. diography to evaluate patients Gith suspected ACS, it is 
Moreover, as can be seen from FIG. 20, there are also four 60 known that ST segment elevation (andor depression) in 
sets of -three contiguous precordial leads” for each type of certain “precordial plus limb lead” combinations can be 
precordial lead configuration: expected to occur when the infarctiodischemia is anatomi- 
cally anterior versus posterior, inferior, lateral, “high lateral” 
etc., in location. Similarly, observations suggest that “pre- 
65 cordial plus limb lead” patterns of changes also occur in the 
HF QRS ECG signals during myocardial ischmeia (Le., 
morphologic RAZs develop in stereotypical lead locations 
set l=leads Vl-V3 (or CR1-CR3); 
set 2=leads V2-V4 (or CR2-CR4); 
set 3=leads V3-V5 (or CR3-CR5); and 
set 4=leads V4-V6 (or CR4-CR6), 
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that “match” with a specifically identified culprit vessel). In the discussion to follow, RCA refers to right coronary 
For example, RAZ,s have been observed in only leads 11, artery; LCx refers to left circumflex coronary artery; LAD 
I11 and aVF plus in leads V5-V6 in patients who have refers to left anterior descending coronary artery; LMCA 
isolated right coronary artery obstructions, even when those refers to left main coronary artery; D1 refers to first diagonal 
patients have no simultaneous changes in their correspond- 5 branch of LAD; and OM1 refers to first obtuse marginal 
ing conventional ST segments. Patterned “limb plus precor- branch of LCx. 
dial lead” changes such as these therefore also need to be Examples of allowed combinations (patterns) may be 
recognized, even when the overall RAZ pattern that is defined, but not restricted to: 
present fails to simultaneously fulfill either the “three spa- “Inferior”, “Right ventricular”, “Posterior” and “Lateral” 
tially contiguous RAZ+” criterion or the “four spatially 10 
contiguous RAZ,, andor RAZ,” criterion. One easily- 
remembered “blanket” method for taking into account the 
most important of the possible “limb plus precordial” lead 
combinations SUSPiCiOUS for CAD Or ACS is to Simply 
accept, as “positive”, any 12-lead HF QRS ECG tracing 15 
wherein a RAz~, a R A z ~  is Present in either “3 
spatially contiguous limb leads plus 2 spatially contiguous 
precordial leads”, andor in “2 spatially contiguous limb 
leads plus 3 spatially contiguous precordial leads”. Under 
this “blanket acceptance” rule, simple calculations reveal 20 
that there are a total of 54 such combinations possible 
whenever all 6 limb leads are used in combination with any 
singular set of 6 precordial leads. Specifically, recalling 
FIGS. 19A, 19B, and 20 above, the sub-criterion “3 spatially 
contiguous limb leads plus two spatially contiguous precor- 25 
dial leads” yields 30 different possible combinations, 
whereas the sub-criterion “2 spatially contiguous limb leads 
plus spatially contiguous precordial leads,, yields 24 
different possible combinations, for a total of 54 different disease: 
possible combinations. When thereafter using the 6 CR 30 RAzA, 
precordial leads in place of the 6 V precordial leads in a I, aVR, 11, v4, v5 
corresponding but separate set of analyses, another 54 such 9, I, aVR, 11, v5, v6 
combinations become possible. 10) aVR, 11, V4, V5, V6 (e.g., LMCA or LAD) 
Some “limb plus precordial lead” combinations tend to 11) I, aVR, V4, V5, V6 (e.g., LMCA or LAD) 
occur more than others in patients with CAD and ACS. 35 Other patterns may be devised to yield diagnostically 
Thus, if one wants to increase test specificity, but possibly at useful results within the scope and spirit of the invention. 
the expense of test sensitivity, less inclusive sets of “limb Another easily imagined permutation of the diagnostic 
plus precordial lead” combinations can be easily constructed criteria allows for positive overall test results on the basis of 
and utilized, albeit clearly still within the spirit of the present having five or more spatially contiguous “Abboud” RAZs, 
invention. For example, one can construct a less inclusive 40 andor “limb plus precordial lead” combinations of Abboud 
set based upon common lead patterns of ST-segment change RAZs occurring in six or more leads. Although it is gener- 
that encompass only those “limb plus precordial lead” ally not an issue for RAZs of the N or AP type, the 
combinations that most often occur in the conventional ECG significance of any single Abboud (A) RAZ can nonetheless 
during acute ischemia. Alternatively, another less inclusive be quite debatable at times, particularly in the limb leads, 
set can be constructed on the basis of the most typical “limb 45 where the overall RMS voltages tend to be smaller than in 
plus precordial lead combinations” in which the HF QRS the central precordial leads. This is shown in respect of FIG. 
RMS voltage has been observed to change during ischemia, 21. 
noting that RMS voltage is a measure of amplitude, whereas FIG. 21 illustrates an HF QRS signal from lead aVF with 
the RAZ and kurtosis measurements germane to present a RAZ, that might be of questionable clinical significance. 
diagnostic criteria are measures of morphology, not ampli- 50 The RAZ, of questionable significance is present near the 
tude. In short, any number of different subsets of “limb plus beginning of the QRS interval. An arrow 320 indicates the 
precordial lead” combinations can be derived and utilized as secondary local maximum defining the RAZ,. This RAZ, 
diagnostic criteria, and each of these could use any of the should be compared to FIG. 16B, in which the RAZ in 
various types of RAZs defined herein andor other measures clearly significant. The RAZ, in the case of FIG. 21 is of 
of HF QRS morphology such as kurtosis, skewness, etc. 55 “questionable” significance because there is very little dif- 
However, any and all of these potential permutations are ference between the absolute amplitude of the envelope 
easily imagined and should be considered encompassed by sample point (secondary local maximum) that defines it and 
the spirit of the present invention. the absolute amplitudes of the envelope sample points that 
One specific example of a subset of “limb plus precordial are immediately adjacent to that secondary local maximum. 
lead” combinations that could be formulated to especially 60 A decision with respect to the legitimacy versus the illegiti- 
enhance the sensitivity and specificity of the 12-lead HF macy of a RAZ, like this is best left to a visually astute and 
QRS ECG technique for detecting disease in the left cir- experienced clinician who also takes into consideration the 
cumflex coronary artery is shown below. This rather exten- characteristics of the HF QRS signals in contiguous leads 11, 
sive example is given because even when severe, angio- I11 etc. However, “automatic diagnosis” decisions related to 
graphic disease restricted to the left circumflex coronary 65 Abboud or other types of RAZs can be legitimized to some 
artery has been historically difficult to diagnose using con- extent by taking into simultaneous consideration the given 
ventional ECG techniques alone. patient’s cardiac axis. 
patterns: 
RAZ,, andor RAZ, or present in each of 
1) 111, aVF, 11, V5, V6 [e.g., RCA or LCx (inferior) or 
2) 111, aVF, 11, V1, V2 [e.g., RCA (right ventricular) or 
3) aVF, 11, aVR, V1, V2 [e.g., potential variant of #2 
4) a ~ ~ ,  I, a ~ ~ ,  v 5 ,  V6 [e,g,, RCA or L C ~ ~ ~ ~ ~  espe- 
5) a ~ ~ ,  I, v 4 ,  ~ 5 ,  v 6  [e,g,, RCA, L C ~  (lateral) or 
possibly LAD] 
~c~ ( p o s ~ e r ~ o r ~ p o s ~ e ~ o r ~ ~ n f e ~ o r ~ ~  
above, especially if LCx] 
cially reference (7)] 
possibly LAD] 
“Anterior,, and “Anterior High Lateral” patterns: 
RAZ,, andor RAZ, present in each of  
6) V2, V3, aVL, 111, aVF (e.g., proximal LAD) 
7) V2, V3, I, aVL, I11 (e.g., D1 branch of LAD; or 
“Global” patterns due to LMCA disease or severe LAD 
RAz, present in each Of 
possibly OM1 branch of LCx) 
LMCA Or LAD) 
LMCA Or LAD) 
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For example, one permutation considers a 12-lead HF 
QRS ECG test “positive” for CAD or some other cardiac 
condition only when a previously defined type of RAZ is 
present in X contiguous leads (and/or in the combination of 
X plus Y contiguous limb+precordial leads) and when it is 
present in both of those limb (or precordial) leads that are 
nearest to the given patient’s cardiac axis in the frontal (or 
horizontal) plane. Imagine, for example, that one planned to 
use “5 spatially contiguous RAZ,” as part of one’s criteria 
for a positive overall test for some cardiac condition. Further 
imagine that a RAZ, was indeed present in all of a given 
patient’s limb leads except lead 11, and at the same time the 
patient’s cardiac frontal plane axis was +70 degrees based on 
the conventional ECG. If the criteria have been permuted so 
as to contain the additional “axis requirement” as noted 
above for the frontal plane, then such a patient would 
actually not have an overall positive test in this case because 
with a cardiac frontal plane axis of +70 degrees, heishe 
would need to have a RAZ, in both leads I1 and aVF (Le., 
in the two leads whose territory is most adjacent to +70 
degrees) to fulfill the permuted criteria. In other words, 
neither of these two leads could be that single lead of the six 
limb leads that is “missing” the RAZ,, and which turns out 
to be the case in this particular example. 
Similarly, when using the “4 spatially contiguous RAZ,, 
and/or RAZ,” criterion permuted with the additional “axis 
requirement” as noted above, a patient with a cardiac frontal 
plane axis of +10 degrees would need to have a RAZ, 
and/or RAZ, specifically present in both leads I and aVR, in 
addition to having such RAZs present in at least 2 of the 
other immediately adjacent limb leads, in order to have a 
positive overall test for CAD, etc. In a patient that has a 
frontal plane cardiac axis of “exactly” -30, 0, 30, 60, 90 or 
120 degrees, then only that single limb lead that points to 
that exact cardiac frontal plane axis (i.e., and not a second 
adjacent lead as well) might be required to be among those 
containing the given required RAZ in order to constitute a 
positive overall test. 
These stated examples represent just a few of the many 
possible permutations within the spirit of the present inven- 
tion that could be generated by utilizing cardiac axis in 
combination with RAZ presenceiabsence in order to formu- 
late slightly variant sets of criteria for diagnoses of cardiac 
conditions, including CAD. Besides combining RAZ pres- 
enceiabsence with cardiac axes, RAZ presenceiabsence 
could also be combined with any number of other objective 
cardiac measures (such as QRS, QT, RR, PR or other 
electrophysiologic intervals, variability or dispersion of 
these same intervals, cardiac ejection fractions, stroke vol- 
umes, tracer uptakes, etc.) and/or with patient features (such 
as height, weight, body mass index, hipiwaistitorso mea- 
surements, various laboratory values, etc.), in order to 
generate even more variant sets of criteria for cardiac 
diagnoses, and all of these easily foreseeable permutations 
should too be considered to fall within the spirit of the 
present invention. 
Functional Operation 
As previously described regarding FIGS. 4 and 5, when 
all hardware components are appropriately connected and 
the patient or subject is attached to the device, natural 
electrical signals from the subject’s heart are first sensed by 
the standard ECG electrodes 12 located on the skin of the 
chest at the conventional 12-lead (i.e., 10 electrode) posi- 
tions. After processing in accordance with the logic shown 
in FIG. 21, the RAZ detectors for each lead 72 provide 
signals to the component 300 for display. In relationship to 
22 
the present invention, the displays depicted in FIGS. 22 and 
23 are representative graphics material in addition to that 
shown and described above. 
FIG. 22 illustrates an HF QRS ECG user interface “Auto- 
5 matic Diagnosis Panel” that takes advantage of the 12-lead 
HF QRS criteria for diagnosis of CAD or ACS just 
described. In the figure, vertical lines indicate the color red, 
horizontal lines indicate gray, cross-hatching indicates yel- 
low, and darkened areas indicate blue. In the specific case 
i o  depicted, the patient’s overall test is “positive” (i.e., suspi- 
cious for CAD in this case), as indicated by the large red 
heart with the “+” sign above it in the upper center portion 
of the figure. Of the 4 individual diagrams (in addition to the 
large red heart) that constitute FIG. 22, only the limb lead 
15 RAZ diagram (upper left) has a small red heart with a “+” 
sign immediately above it, whereas the other three indi- 
vidual diagrams have small gray hearts with “-” signs above 
them, indicating their individually negative status. The 
upper left hand diagram (i.e., the limb lead RAZ diagram) is 
20 positive in this case because it is showing the simultaneous 
presence of a RAZ, in each of the three contiguous limb 
leads 11, aVF and 111, as indicated by the outermost (red) 
shading in those leads. If any one of the four individual 
diagrams is positive, or, for the RAZ,, and RAZ, (both 
25 indicated by yellow shading when present), if combinational 
diagrams (i.e., limb+limb or precordial+precordial or limb+ 
precordial) are positive for a “diagnostic combination” (the 
latter is also the case here because RAZ,, and RAZ, 
combined are also present in the accepted combination of 
30 leads 11, aVF, 111, V5 and V6, as outlined in the text), then 
by definition, the entire test is positive, and the large heart 
becomes red and “+”. In the present case, the precordial 
RAZ diagram (lower left) is by itself negative because it 
does not reveal 3 contiguous RAZ, (Le., only lead V6 has a 
35 RAZ,), nor four contiguous RAZ, (only leads V5 and V6 
have RAZ,,). Similarly, both the limb lead and the precor- 
dial lead kurtosis diagrams (right side of figure) are negative 
by themselves in this case because neither of these diagrams 
shows the presence of four contiguous RAZE Note that the 
40 innermost (blue) shading represents the presence of a RAZ, 
(in the RAZ diagrams) and the presence of a “gray zone” 
level of kurtosis (in the kurtosis diagrams). 
FIG. 23 illustrates an HF QRS user interface “Automatic 
Diagnosis Panel” that depicts an overall negative test for 
45 CAD, as indicated by the large gray heart with the “-” sign 
above it in the upper center portion of the figures. This 
patient’s test is overall negative because all four diagrams 
are individually negative, and also because there are no 
positive “RAZ,dRAZ, combinations” present. The upper 
50 left hand diagram (Le., the limb lead RAZ diagram) is 
negative because it does not reveal 3 contiguous RAZJa 
RAZ, is present only in limb lead aVF, outermost (red) 
shading] nor four contiguous RAZ,, [a RAZ,, is present 
only in limb lead aVF, middle-layer (yellow) shading]. The 
55 precordial RAZ diagram (lower left) is likewise negative 
because it does not reveal 3 contiguous RAZ, (i.e., no 
precordial lead has a RAZ,), nor four contiguous RAZ, 
[only precordial lead V2 has a RAZ,,, middle-layer (yel- 
low) shading]. Similarly, both the limb lead and the precor- 
60 dial lead kurtosis diagrams (right side of figure) are again 
negative in this case because neither of those diagrams 
shows the presence of four contiguous RAZ, [outermost 
(yellow) shading]. Combining the RAZ, and/or the RAZ, 
that are present across the limb leads or across the precordial 
65 leads also does not lead to a “four contiguous RAZ” phe- 
nomoneon, nor are there any combinations of such RAZs 
present in the allowed configurations of “3 contiguous limb 
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leads+2 contiguous precordial leads” or “2 contiguous 
limb+3 contiguous precordial leads”. 
The principles, preferred embodiment, and mode of 
operation of the present invention have been described in the 
foregoing specification. This invention is not to be construed 
as limited to the particular forms disclosed, since these are 
regarded as illustrative rather than restrictive. Moreover, 
variations and changes may be made by those skilled in the 
art without departing from the spirit of the invention. 
We claim: 
1. An electrocardiograph system comprising: 
means for sensing a plurality of electrocardiograph sig- 
nals, the signals comprising cardiac data and a succes- 
sion of waves; 
means for independently identifying the QRS complex in 
each wave; 
means for signal-averaging the QRS complex in each 
wave; 
means for band-pass filtering the signal-averaged QRS 
complex in a high frequency range thereby deriving 
high frequency components of the QRS complex, 
wherein the means for band-pass filtering passes fre- 
quencies from 150 Hz to 250 Hz; 
means for detecting a reduced amplitude zone within the 
high frequency components of the QRS complex in 
each wave relating to cardiac function, the reduced 
amplitude zone within the high frequency components 
of the QRS complex comprising RAZ data; 
means for relating at least three of the detected reduced 
amplitude zones in accordance with predetermined 
criteria to develop cardiac diagnoses; and 
means for displaying the cardiac and RAZ data in real 
time on a monitor. 
2. The system of claim 1, wherein the reduced amplitude 
zone is defined as a region within the high frequency 
components of the QRS complex lying between two neigh- 
boring maxima or minima. 
3. The system of claim 1, wherein the reduced amplitude 
zone is defined as a region within the high frequency 
components of the QRS complex lying between two neigh- 
boring maxima or minima, and wherein a second, smaller 
local maximum or minimum within the high frequency 
components of the QRS complex is at least a certain 
user-selectable percentage of the larger of the maxima or 
minima. 
4. The system of claim 3, wherein the percentage is any 
percentage between 0% and 100%. 
5. The system of claim 1, wherein the reduced amplitude 
zone is defined as a region within the high frequency 
components of the QRS complex lying between two neigh- 
boring maxima or minima, and wherein the voltage of a 
second, smaller local maximum within the high frequency 
components of the QRS complex is at least a certain 
user-selectable percentage of that of the larger of the 
maxima or wherein the voltage of a second, smaller local 
minimum within the high frequency components of the QRS 
complex is at least a certain user-selectable percentage of 
that of the larger of the minima. 
6. The system of claim 1, further comprising means for 
analyzing a kurtosis of the high frequency components of 
the QRS complex and determining the kurtosis below a 
predetermined minimum. 
7. The system of claim 1, wherein the means for sensing 
a plurality of electrocardiograph signals comprise a plurality 
of electrodes, and wherein the electrodes are defined in 
spatial relation to one another. 
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8. The system of claim 7, wherein the means for relating 
at least three of the detected reduced amplitude zones, relate 
the reduced amplitude zones in terms of spatial relation. 
9. The system of claim 7, wherein the means for relating 
5 includes means for relating all of the detected reduced 
amplitude zones from the means for detecting. 
10. The system of claim 1, further comprising: 
means for recording a first set of baseline cardiac and 
RAZ data; and 
means for comparing the first set of baseline cardiac and 
RAZ data with cardiac and RAZ data captured in real 
time. 
11. The system of claim 10, wherein the means for 
15 displaying the cardiac data and the RAZ data in real-time on 
a monitor includes means for displaying the first set of 
baseline cardiac and RAZ data along with cardiac and RAZ 
data captured in real time. 
12. The system of claim 1, wherein the means for sensing 
20 a plurality of electrocardiograph signals includes CR pre- 
13. The system of claim 1, wherein the means for signal- 
10 
cordial leads. 
averaging is comprised of: 
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means for developing a time-varying, signal-averaged 
template based on the QRS complex in each wave from 
each of the means of sensing; 
means for cross-correlating the QRS complex in each 
wave in real time from each of the means of sensing 
with a respective time-varying, signal-averaged tem- 
plate; and 
means for accepting or rejecting each QRS complex in 
each wave based on the means for cross-correlating, 
wherein accepted QRS complexes are incorporated into 
the time-varying, signal-averaged template. 
14. The system of claim 13 further comprising: 
means for recording data, wherein the data are comprised 
of the signals; the time-varying, signal-averaged tem- 
plate; the RAZ data; or any combination; and 
means for indicating likely coronary artery disease, acute 
coronary syndrome, or other cardiac condition from the 
recorded data when a reduced amplitude zone is present 
in each of three or more sensing means, wherein the 
sensing means are spatially contiguous. 
15. The system of claim 13, 
wherein the reduced amplitude zone is comprised of an 
Abboud RAZ, Abboud Percent RAZ, a NASA RAZ, 
Kurtosis RAZ, or any combination, and 
wherein the predetermined criteria are comprised of a 
predetermined percentage occurrence of the Abboud 
RAZ, Abboud Percent RAZ, NASA RAZ, Kurtosis 
RAZ, or any combination within a predetermined num- 
ber of the accepted QRS complexes from at least one of 
the plurality of electrocardiograph signals. 
16. The system of claim 13, 
wherein the reduced amplitude zone is comprised of an 
Abboud RAZ, Abboud Percent RAZ, a NASA RAZ, 
Kurtosis RAZ, or any combination, and 
wherein the predetermined criteria are comprised of an 
occurrence of the Abboud RAZ, Abboud Percent RAZ, 
NASA RAZ, Kurtosis RAZ, or any combination when 
derived from the final time-varying, signal-averaged 
template. 
* * * * *  
